Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study

​ Conditions: Breast Cancer

Interventions: Drug: Cyclin-dependent Kinase 4/6 Inhibitor

Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Active, not recruiting Conditions: Breast Cancer
Interventions: Drug: Cyclin-dependent Kinase 4/6 Inhibitor
Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Active, not recruiting